Garg Rajat, Gupta Shradha, Singh Amandeep, Simonson Marian T, Rustagi Tarun, Chahal Prabhleen
Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA.
Department of Internal Medicine, Chandler Regional Medical Center, Division of Gastroenterology, Mayo Clinic, Phoenix, AZ, USA.
Pancreatology. 2021 Dec;21(8):1540-1547. doi: 10.1016/j.pan.2021.09.007. Epub 2021 Sep 21.
Endoscopic necrosectomy (EN) is the preferred approach for management of symptomatic or infected walled-off pancreatic necrosis (WOPN). Hydrogen peroxide (HO) has been reported to be a good adjunctive therapy for EN. We performed a systematic review and meta-analysis to evaluate effectiveness and safety of HO assisted EN for WOPN.
A comprehensive search of multiple databases (through December 2020) was performed to identify studies that reported outcomes of HO assisted EN for WOPN. Outcomes assessed included clinical success, technical success, and adverse events.
A total of 454 patients with mean age (47.3 ± 7.9 years) and WOPN size (12.4 ± 3.1 cm) were included from 15 studies. The median HO concentration was 3% (range 0.1-3%), with dilution and volume ranging from 1:1 to 10:1 and 20 ml to 1 L, respectively. The rates of technical success, clinical success and adverse events was 97.3% (95% confidence interval [CI]: 94.8-98.6, I = 0), 89.8% (95% CI: 86.3-92.5, I = 0) and 17.9% (95% CI: 12.6-24.7, I = 38), respectively. The most common adverse event was bleeding (7.1%) followed by stent migration (5.3%). On meta-regression, WOPN size, patient age, use of metal stent, number of necrosectomies and transgastric access were not significant predictor for technical success, clinical success or adverse events.
HO assisted EN is effective and safe for management of WOPN. Its use may be encouraged, and future randomized controlled studies are needed to study the optimal technique, concentration and best predictors of success.
内镜坏死组织清除术(EN)是治疗有症状或感染性包裹性胰腺坏死(WOPN)的首选方法。据报道,过氧化氢(HO)是EN的一种良好辅助治疗方法。我们进行了一项系统评价和荟萃分析,以评估HO辅助EN治疗WOPN的有效性和安全性。
对多个数据库进行全面检索(截至2020年12月),以确定报告HO辅助EN治疗WOPN结果的研究。评估的结果包括临床成功、技术成功和不良事件。
15项研究共纳入454例患者,平均年龄(47.3±7.9岁),WOPN大小(12.4±3.1cm)。HO的中位浓度为3%(范围0.1-3%),稀释比例和体积分别为1:1至10:1和20ml至1L。技术成功率、临床成功率和不良事件发生率分别为97.3%(95%置信区间[CI]:94.8-98.6,I=0)、89.8%(95%CI:86.3-92.5,I=0)和17.9%(95%CI:12.6-24.7,I=38)。最常见的不良事件是出血(7.1%),其次是支架移位(5.3%)。在meta回归分析中,WOPN大小、患者年龄、金属支架的使用、坏死组织清除术的次数和经胃入路不是技术成功、临床成功或不良事件的显著预测因素。
HO辅助EN治疗WOPN是有效且安全的。可以鼓励使用,未来需要进行随机对照研究以探讨最佳技术、浓度和成功的最佳预测因素。